Sexual Health
ELI 20
CLASSIFICATION: PDE5 INHIBITOR
ACTIVE SUBSTANCE: TADALAFIL CITRATE
FORM: 200 PILLS x 20 MG
ACTIVE HALF-LIFE: 17.5 HOURS
DOSAGE: MEN 10-20 MG/DAY
ACNE: NO
WATER RETENTION: NO
HBR: PERHAPS
HEPATOTOXICITY: NO
AROMATIZATION: NO
MANUFACTURER: AUROCHEM LABORATORIES
ACTIVE SUBSTANCE: TADALAFIL CITRATE
FORM: 200 PILLS x 20 MG
ACTIVE HALF-LIFE: 17.5 HOURS
DOSAGE: MEN 10-20 MG/DAY
ACNE: NO
WATER RETENTION: NO
HBR: PERHAPS
HEPATOTOXICITY: NO
AROMATIZATION: NO
MANUFACTURER: AUROCHEM LABORATORIES
Out of stock
Trusted Aurochem Laboratories Eli 20 Source
No reviews found
Please log in to write ELI 20 review.
Related Offers
Lab Tested
NEW
Shipped International
British Dragon Pharmaceuticals
CLASSIFICATION: PDE5 INHIBITOR
ACTIVE SUBSTANCE: TADALAFIL CITRATE
FORM: 100 TABLETS × 20 MG
ACTIVE HALF-LIFE: 36 HOURS
DOSAGE: 10–20 MG AS NEEDED
ACNE: NO
WATER RETENTION: NO
HIGH BLOOD PRESSURE (HBP): RARE
HEPATOTOXICITY: NONE
AROMATIZATION: NO
MANUFACTURER: BRITISH DRAGON
LABORATORY TESTED: VIEW LAB RESULTS
$60.00
NEW
Shipped International
Axiolabs
CLASSIFICATION: PDE5 INHIBITOR
ACTIVE SUBSTANCE: TADALAFIL CITRATE
FORM: 100 PILLS x 20 MG
ACTIVE HALF-LIFE: 17.5 HOURS
DOSAGE: MEN 10-20 MG/DAY
ACNE: NO
WATER RETENTION: NO
HIGH BLOOD PRESSURE (HBP): PERHAPS
HEPATOTOXICITY: NO
AROMATIZATION: NO
MANUFACTURER: AXIOLABS
$60.00
Lab Tested
Stealth Labs
CLASSIFICATION: ERECTILE DYSFUNCTION (PDE5 INHIBITOR)
ACTIVE SUBSTANCE: TADALAFIL CITRATE
FORM: 100 TABLETS (50 MG/TABLET)
ACTIVE HALF-LIFE: ~ 36 HOURS
DOSAGE: 10–50 MG PER USE OR 5–10 MG DAILY
ACNE: NONE
WATER RETENTION: NONE
HIGH BLOOD PRESSURE (HBP): LOW RISK (MONITOR)
HEPATOTOXICITY: NONE
AROMATIZATION: NONE
MANUFACTURER: STEALTH LABS USA
LABORATORY TESTED: VIEW LAB RESULTS
SHIPPED WITHOUT LABEL!
Lab Tested
Domestic & International
Buy 3 and get 1 for FREE
Dragon Pharma, Europe
CLASSIFICATION: PDE5 INHIBITOR
ACTIVE SUBSTANCE: TADALAFIL CITRATE
FORM: 100 PILLS x 20 MG
ACTIVE HALF-LIFE: 17.5 HOURS
DOSAGE: MEN 10-20 MG/DAY
ACNE: NO
WATER RETENTION: NO
HIGH BLOOD PRESSURE (HBP): PERHAPS
HEPATOTOXICITY: NO
AROMATIZATION: NO
MANUFACTURER: DRAGON PHARMA
LABORATORY TESTED: VIEW LAB RESULTS
$61.00
Shipped International
Kalpa Pharmaceuticals LTD, India
CLASSIFICATION: PDE5 INHIBITOR (ERECTILE DYSFUNCTION AGENT)
ACTIVE SUBSTANCE: TADALAFIL CITRATE
FORM: 100 TABLETS x 20 MG
ACTIVE HALF-LIFE: 17.5 HOURS
DOSAGE: 10–20 MG AS NEEDED
ACNE: NO
WATER RETENTION: NO
HIGH BLOOD PRESSURE (HBP): MAY LOWER
HEPATOTOXICITY: NO
AROMATIZATION: NO
MANUFACTURER: KALPA PHARMACEUTICALS
$61.00
Centurion Laboratories
CLASSIFICATION: PDE5 INHIBITOR
ACTIVE SUBSTANCE: TADALAFIL CITRATE
FORM: 100 PILLS x 20 MG
ACTIVE HALF-LIFE: 17.5 HOURS
DOSAGE: MEN 10-20 MG/DAY
ACNE: NO
WATER RETENTION: NO
HBR: PERHAPS
HEPATOTOXICITY: NO
AROMATIZATION: NO
MANUFACTURER: CENTURION LABORATORIES
ACTIVE SUBSTANCE: TADALAFIL CITRATE
FORM: 100 PILLS x 20 MG
ACTIVE HALF-LIFE: 17.5 HOURS
DOSAGE: MEN 10-20 MG/DAY
ACNE: NO
WATER RETENTION: NO
HBR: PERHAPS
HEPATOTOXICITY: NO
AROMATIZATION: NO
MANUFACTURER: CENTURION LABORATORIES
Macleods
CLASSIFICATION: PDE5 INHIBITOR
ACTIVE SUBSTANCE: TADALAFIL CITRATE
FORM: 16 PILLS x 10 MG
ACTIVE HALF-LIFE: 17.5 HOURS
DOSAGE: MEN 10-20 MG/DAY
ACNE: NO
WATER RETENTION: NO
HBR: PERHAPS
HEPATOTOXICITY: NO
AROMATIZATION: NO
MANUFACTURER: MACLEODS
ACTIVE SUBSTANCE: TADALAFIL CITRATE
FORM: 16 PILLS x 10 MG
ACTIVE HALF-LIFE: 17.5 HOURS
DOSAGE: MEN 10-20 MG/DAY
ACNE: NO
WATER RETENTION: NO
HBR: PERHAPS
HEPATOTOXICITY: NO
AROMATIZATION: NO
MANUFACTURER: MACLEODS
Fortune Health Care
CLASSIFICATION: PDE5 INHIBITOR
ACTIVE SUBSTANCE: TADALAFIL CITRATE
FORM: 100 PILLS x 20 MG
ACTIVE HALF-LIFE: 17.5 HOURS
DOSAGE: MEN 10-20 MG/DAY
ACNE: NO
WATER RETENTION: NO
HBR: PERHAPS
HEPATOTOXICITY: NO
AROMATIZATION: NO
MANUFACTURER: FORTUNE HEALTH CARE
ACTIVE SUBSTANCE: TADALAFIL CITRATE
FORM: 100 PILLS x 20 MG
ACTIVE HALF-LIFE: 17.5 HOURS
DOSAGE: MEN 10-20 MG/DAY
ACNE: NO
WATER RETENTION: NO
HBR: PERHAPS
HEPATOTOXICITY: NO
AROMATIZATION: NO
MANUFACTURER: FORTUNE HEALTH CARE